Literature DB >> 20237755

Clinical course and mortality risk factors in critically ill children requiring continuous renal replacement therapy.

Maria J Santiago1, Jesús López-Herce, Javier Urbano, Maria José Solana, Jimena del Castillo, Yolanda Ballestero, Marta Botrán, Jose María Bellón.   

Abstract

OBJECTIVE: To study the clinical course in children requiring continuous renal replacement therapy (CRRT) and to analyse factors associated with mortality.
DESIGN: Prospective observational study.
SETTING: Paediatric intensive care department of a tertiary university hospital. PATIENTS: Critically ill children with CRRT were included in the study. INTERVENTION: Continuous renal replacement therapy. MEASUREMENTS AND
RESULTS: Univariate and multivariate analyses were performed to analyse the influence of each factor on mortality. The ability of the PRISM, PIM II and PELOD severity of illness scores to predict mortality was tested using receiver-operating characteristic curve statistics. A total of 174 children aged between 1 month and 22 years were treated with CRRT. Mortality was 35.6%, and multiorgan failure and haemodynamic disturbances were the principal causes of death. Mortality was higher in children less than 12 months of age (44.7%; P = 0.037) and in patients with a diagnosis of sepsis (44.1%; P = 0.001). Haemodynamic disturbances at the time of starting CRRT (hypotension or need for adrenaline >0.6 microg/kg/min) and the presence of multiorgan failure were the factors associated with an increased risk of mortality. The PRISM scale was the severity score with the best predictive capacity, although all three scales underestimated the actual mortality.
CONCLUSIONS: Mortality in children who require CRRT is high. Haemodynamic disturbances and the presence of multiorgan failure at the time of starting the technique are the factors associated with a higher mortality. The clinical severity scores underestimate mortality in children requiring CRRT.

Entities:  

Mesh:

Year:  2010        PMID: 20237755     DOI: 10.1007/s00134-010-1858-9

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  47 in total

1.  Predicting the outcome of renal replacement therapy in severe acute renal failure.

Authors:  Crystal Martin; Rajiv Saran; Sean Leavey; Richard Swartz
Journal:  ASAIO J       Date:  2002 Nov-Dec       Impact factor: 2.872

Review 2.  Causes, management approaches, and outcome of acute renal failure in children.

Authors:  J T Flynn
Journal:  Curr Opin Pediatr       Date:  1998-04       Impact factor: 2.856

3.  Epidemiology, management, and outcome of severe acute renal failure of critical illness in Australia.

Authors:  W Silvester; R Bellomo; L Cole
Journal:  Crit Care Med       Date:  2001-10       Impact factor: 7.598

4.  Continuous renal replacement therapy in children up to 10 kg.

Authors:  Jordan M Symons; Patrick D Brophy; Melissa J Gregory; Nancy McAfee; Michael J G Somers; Timothy E Bunchman; Stuart L Goldstein
Journal:  Am J Kidney Dis       Date:  2003-05       Impact factor: 8.860

5.  Six-month outcome in acute kidney injury requiring renal replacement therapy in the ICU: a multicentre prospective study.

Authors:  B Delannoy; B Floccard; F Thiolliere; M Kaaki; M Badet; S Rosselli; C E Ber; A Saez; G Flandreau; Claude Guérin
Journal:  Intensive Care Med       Date:  2009-08-20       Impact factor: 17.440

6.  Demographic characteristics of pediatric continuous renal replacement therapy: a report of the prospective pediatric continuous renal replacement therapy registry.

Authors:  Jordan M Symons; Annabelle N Chua; Michael J G Somers; Michelle A Baum; Timothy E Bunchman; Mark R Benfield; Patrick D Brophy; Douglas Blowey; James D Fortenberry; Deepa Chand; Francisco X Flores; Richard Hackbarth; Steven R Alexander; John Mahan; Kevin D McBryde; Stuart L Goldstein
Journal:  Clin J Am Soc Nephrol       Date:  2007-05-18       Impact factor: 8.237

7.  Epidemiology and outcome of acute kidney injury in New Zealand children.

Authors:  Emma F Ball; Tonya Kara
Journal:  J Paediatr Child Health       Date:  2008-08-19       Impact factor: 1.954

Review 8.  Acute kidney failure: a pediatric experience over 20 years.

Authors:  Debra M Williams; Sue S Sreedhar; John J Mickell; James C M Chan
Journal:  Arch Pediatr Adolesc Med       Date:  2002-09

9.  An assessment of acute kidney injury with modified RIFLE criteria in pediatric patients with severe burns.

Authors:  Tina Palmieri; Athina Lavrentieva; David Greenhalgh
Journal:  Intensive Care Med       Date:  2009-09-15       Impact factor: 17.440

10.  A positive fluid balance is associated with a worse outcome in patients with acute renal failure.

Authors:  Didier Payen; Anne Cornélie de Pont; Yasser Sakr; Claudia Spies; Konrad Reinhart; Jean Louis Vincent
Journal:  Crit Care       Date:  2008-06-04       Impact factor: 9.097

View more
  16 in total

1.  Pediatric continuous renal replacement: 20 years later.

Authors:  Claudio Ronco; Zaccaria Ricci
Journal:  Intensive Care Med       Date:  2015-04-17       Impact factor: 17.440

Review 2.  Specific Etiologies Associated With the Multiple Organ Dysfunction Syndrome in Children: Part 2.

Authors:  Jeffrey S Upperman; John C Bucuvalas; Felicia N Williams; Bruce A Cairns; Charles S Cox; Allan Doctor; Robert F Tamburro
Journal:  Pediatr Crit Care Med       Date:  2017-03       Impact factor: 3.624

3.  Regional citrate anticoagulation for pediatric CRRT using integrated citrate software and physiological sodium concentration solutions.

Authors:  Jean-Michel Liet; Emma Allain-Launay; Bénédicte Gaillard-LeRoux; François Barrière; Alexis Chenouard; Jean-Marc Dejode; Nicolas Joram
Journal:  Pediatr Nephrol       Date:  2014-02-15       Impact factor: 3.714

Review 4.  Pediatric renal replacement therapy in the intensive care unit.

Authors:  Brian C Bridges; David J Askenazi; Jessimene Smith; Stuart L Goldstein
Journal:  Blood Purif       Date:  2012-10-24       Impact factor: 2.614

5.  Treatment of critically ill children with kidney injury by sustained low-efficiency daily diafiltration.

Authors:  Chia-Ying Lee; Huang-Chieh Yeh; Ching-Yuang Lin
Journal:  Pediatr Nephrol       Date:  2012-08-18       Impact factor: 3.714

6.  The accuracy of a continuous volumetric balancing system in pediatric continuous renal replacement therapy.

Authors:  Mark R Hanudel; Isidro B Salusky; Joshua J Zaritsky
Journal:  Int J Artif Organs       Date:  2014-04-04       Impact factor: 1.595

7.  Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012.

Authors:  R P Dellinger; Mitchell M Levy; Andrew Rhodes; Djillali Annane; Herwig Gerlach; Steven M Opal; Jonathan E Sevransky; Charles L Sprung; Ivor S Douglas; Roman Jaeschke; Tiffany M Osborn; Mark E Nunnally; Sean R Townsend; Konrad Reinhart; Ruth M Kleinpell; Derek C Angus; Clifford S Deutschman; Flavia R Machado; Gordon D Rubenfeld; Steven Webb; Richard J Beale; Jean-Louis Vincent; Rui Moreno
Journal:  Intensive Care Med       Date:  2013-01-30       Impact factor: 17.440

8.  Continuous renal replacement therapy in children: fluid overload does not always predict mortality.

Authors:  Lara de Galasso; Francesco Emma; Stefano Picca; Matteo Di Nardo; Emanuele Rossetti; Isabella Guzzo
Journal:  Pediatr Nephrol       Date:  2015-11-12       Impact factor: 3.714

9.  Nutritional status and clinical outcome of children on continuous renal replacement therapy: a prospective observational study.

Authors:  Ana Castillo; Maria J Santiago; Jesús López-Herce; Sandra Montoro; Jorge López; Amaya Bustinza; Ramón Moral; Jose M Bellón
Journal:  BMC Nephrol       Date:  2012-09-27       Impact factor: 2.388

10.  Cisplatin-Induced Non-Oliguric Acute Kidney Injury in a Pediatric Experimental Animal Model in Piglets.

Authors:  Maria José Santiago; Sarah Nicole Fernández; Alberto Lázaro; Rafael González; Javier Urbano; Jorge López; Maria José Solana; Blanca Toledo; Jimena Del Castillo; Alberto Tejedor; Jesús López-Herce
Journal:  PLoS One       Date:  2016-02-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.